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Abstract
Objective
We clinically and molecularly characterize a new family with autosomal dominant rimmed
vacuolar myopathy (RVM) caused by mutations in the HSPB8 gene.
Methods
We performed whole-exome and whole-genome sequencing in the family. Western blot and
immunocytochemistry were used to analyze 3 patient ﬁbroblasts, and ﬁndings were compared
with their age- and sex-matched controls.
Results
Aﬀected patients have distal and proximal myopathy, with muscle biopsy showing rimmed
vacuoles, muscle ﬁber atrophy, and endomysial ﬁbrosis typical of RVM. Muscle MRI showed
severe relatively symmetric multifocal fatty degenerative changes of the lower extremities. We
identiﬁed a duplication of C at position 515 of theHSPB8 gene (c.515dupC) by whole-genome
sequencing, which caused a frameshift with a predicted alternate stop codon p.P173SFS*43 in
all aﬀected individuals, resulting in an elongated protein product. Western blot and immu-
nocytochemistry studies revealed reduced expression of heat shock protein beta 8 in patient
ﬁbroblasts compared with control ﬁbroblasts, in addition to disrupted autophagy pathology.
Conclusions
We report a novel family with autosomal dominant RVM caused by the c.515dupCmutation of
the HSPB8 gene, causing a translational frameshift that results in an elongated protein. Un-
derstanding the mechanism for the RVM pathology caused by mutated chaperone will permit
novel targeted strategies to alter the natural history progression. As next-generation sequencing
becomesmore available, additional myopathic families will be identiﬁed withHSPB8mutations.
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Heat shock protein beta 8 (HSPB8), also known as heat shock
protein 22, is involved in chaperone-assisted selective autophagy
(CASA) in cells.1 CASA is a process that maintains muscle
cytoskeleton by facilitating the degradation of damaged com-
ponents. Disruption of genes in the chaperone-assisted degra-
dation pathway is implicated in several myopathies. CASA
interacts with ﬁlamin C (FLNC), a ﬂexible actin cross-linker that
is present within muscle Z-disks2 and along cytoskeleton-
associated integrin where it functions to anchor actin during
mechanical stress.3 DnaJ Heat Shock Protein Family (Hsp40)
Member B6 (DNAJB6) thought to be the ﬁrst protein that
interacts with Heat Shock Protein Family A (Hsp70)Member 8
(HSPA8)4 then complexes with HSPB8. BCL2 Associated
Athanogene 3 (BAG3) is a coupling factor thatmediatesHSPA8
and HSPB8 interaction.1 Mutations of several CASA-associated
proteins are known to be associated with myopathies: DNAJB6
is associated with limb-girdle muscular dystrophy 1D,5 BAG3,6,7
and FLNC with skeletal and cardiac myopathies.8,9
Previous studies associated HSPB8 mutations with Charcot-
Marie-Tooth (CMT) type 2L10,11 and distal hereditary motor
neuropathy type IIa.12 It was only after an exome analysis that
the association with distal myoﬁbrillar and rimmed vacuolar
neuromyopathy was established,13 identifying a heterozygous
change in HSPB8 in 2 families: c.421A>G; p.K141E in family
1 and the c.515 insC p.P173SfsX43 in family 2. Aﬀected
patients had a distal neuromyopathy that showed myoﬁbrillar
aggregates and rimmed vacuoles combined with a clear neu-
rogenic component on biopsy and EMG studies. Recently,
a c.508_509delCA mutation was identiﬁed, predicted to
produce a frameshift mutation leading to alteration of the last
27 amino acids and elongation of the polypeptide by 17 res-
idues in 3 families.14 Finally, a family was identiﬁed with
c.421A>G p.K141E HSPB8 mutations manifesting with pes
cavus, hammer toes, and muscle atrophy with biopsy ﬁndings
including rimmed vacuoles and myopathic changes.15 Here,
we describe a new family with anHSPB8 p.Pro173fs mutation
manifesting as rimmed vacuolar myopathy (RVM).
Methods
Standard protocol approvals, registrations,
and patient consents
This study was approved by the University of California Irvine
Institutional Review Board (#2009-1005). All subjects pro-
vided approved consent for the studies. The study is also listed
in ClinicalTrials.gov (Identiﬁer: NCT01353430).
Molecular studies
Extensive gene panel of the genes involved in neuromuscular
diseases performed by EGL Genetics Diagnostic Laboratory
at Emory University was negative for the following 35 genes:
AN05, CAPN3, CAV3, COL6A1, COL6A2, COL6A3, DAG1,
DES, DMD, DYSF, EMO, FHL1, FKRP, FKTN, FLNC, GAA,
GNE, ISPD, LMNA, MYOT, PLEC, POMGNT1, POMT1,
POMT2, SGCA, SGCB, SGCD, SGCG, SMCHD1, SYNE1,
SYNE2, TCAP, TRIM32, TTN, and VCP.
Whole-exome sequencing and segregation analysis was per-
formed by Ambry Genetics.16 Brieﬂy, the sample was pre-
pared using the IDT xGen Exome Research Panel V1.0
(Integrated DNA Technologies), sequenced using the Illu-
mina HiSeq4000 sequencer (Illumina, San Diego, CA). Data
processing and interpretation were performed as previously
described.16
Subsequent genome sequencing was performed by Otoge-
netics Corporation (Atlanta, GA) and the data analyzed by
Variantyx, Inc. (Framingham, MA). For sequencing, libraries
were generated using the Truseq Nano DNA Library Sample
preparation Kit and sequenced on the Illumina HiSeq X Ten
system (Illumina, USA) to achieve average read depth of
about 30X. Variants were detected, annotated, analyzed, and
reported using the Genomic Intelligence platform (version 1/
.13.2.0) integrating the knowledge in a variety of databases
and tools (Variantyx Inc). Sanger sequencing was used to
conﬁrm theHSPB8 variant in the proband and for segregation
studies in his family.
HSPB8 protein study and autophagic activity of
mutant HSPB8
Because of the unavailability of patient myoblasts, we studied
patient ﬁbroblasts from the proband, his mother, and mater-
nal uncle derived from skin biopsy samples (P1: 64-001, P2:
64-002, P3: 64-005). Fibroblasts of the 3 age- and sex-
matched healthy controls from Coriell Repository (C1:
GM22246, C2: AG12786, C3: AM03529A) were used to test
the HSPB8 expression level for comparison. Western blotting
and immunocytochemistry studies using HSPB8 antibody
(Millipore Sigma HPA015876) were performed as previously
described.17 We also monitored the autophagic activity of
mutant HSPB818 using autophagosomal markers LC3B
(Abcam, ab48394), P62/SQSTM1 (ab56416), and BAG3
(ab47124) antibodies.
HSPB8 protein expression under heat
shock conditions
Under stress conditions such as heat shock, the concentration
of small heat shock proteins such as HSPB8 would be
expected to increase to perform their chaperone activity of
binding to misfolded proteins and blocking the formation of
aggregates.19,20 The heat shock experiment was performed as
Glossary
CASA = chaperone-assisted selective autophagy;CMT =Charcot-Marie-Tooth; FLNC = ﬁlamin C;HSPB = heat shock protein
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follows: ﬁbroblasts were seeded on chambered slides (Ibidi,
IbiTreat 80826) in subconﬂuent density for 24 hours. The
slides were sealed with paraﬁlm, placed in an aluminum foil
box, and immersed in 43°C water bath for 30 minutes. Un-
heated control slides were also sealed for 30 minutes but kept
in an incubator (37°C). Then, all slides were unsealed, and
their recovery was followed for 24 hours in the incubator
before immunocytochemistry was performed.19,20
Data availability
All the data from this study will be made available.
Results
Clinical studies
Case 1
The proband (IV:8) is a 44-year-old man born to non-
consanguineous Northern European parents of French an-
cestry with a family history of autosomal dominant
inheritance of muscle weakness in his mother and his ma-
ternal uncle (ﬁgure 1). He was an all-state athlete in his 20s.
He had persistent elevated liver enzymes from age 28 years
and ﬁrst noticed lower limb weakness in the mid-30s with
progressive bilateral foot drop and occasional falls. At age 35
years, he developed foot pain and ankle dorsiﬂexion weakness
for which he wore ankle foot orthoses. At age 42 years, he
noticed diﬃculty raising his arms above his head, and at age 43
years, diﬃculty rising from a chair and climbing stairs.
On physical examination, there was mild scapular winging
(ﬁgure 2), diﬀuse muscle weakness noted predominantly in
the lower extremities, and no sensory loss. He had a wide
steppage gait related to his bilateral foot drop, was unable to
tandem walk or walk on his heels or toes, and had a lumbar
lordosis. TheMedical Research Council (MRC) scale score of
his foot dorsiﬂexors was 2/5, and that of the extensor hal-
lucis longus was 1/5 on the right and 2/5 on the left. The
MRC scale score of the infraspinatus, deltoid, ﬁnger
extensors, hip ﬂexors, hip extensors, knee ﬂexors, hip
adductors, and hip abductors was 4/5. Reﬂexes were di-
minished 1/4 bilaterally of the biceps, triceps, brachior-
adialis, knee, and absent at the ankle. T1-weighted MRI
showed severe relatively symmetric multifocal fatty de-
generative changes of the lower extremities, preferentially
aﬀecting the vastus medialis and intermedius, adductor
magnus and semitendinosus at the thigh level, and pre-
dominantly anterior and lateral compartments more than
calf muscle of the lower legs (ﬁgure 2, B and C). Laboratory
studies revealed normal comprehensive metabolic proﬁle,
normal alkaline phosphatase 28 U/L, and elevated total
cholesterol 237 mg/dL (normal < 150 mg/dL). His medical
history included asymptomatic right bundle branch block,
pseudogout, benign prostatic hyperplasia, and rosacea. Al-
though he was asymptomatic, pulmonary function studies
revealed respiratory insuﬃciency with decreased Forced
Vital Capacity (sitting) of 4 L (43% of predicted). His
maximum inspiratory pressure was −72 cmH2O. BiPAP was
recommended for his respiratory insuﬃciency. The patient
is taking nonprescribed nutritional supplements.
Case 2
The proband’s mother (III:14) aged 64 years ﬁrst presented
with diﬃculty raising her arms and weakness in her legs and
feet not until age 56 years. She then progressed to having
diﬃculty walking up stairs at age 59 years and developed
diﬃculty walking on ﬂat ground and weakness in her hands at
age 60 years. Her medical history included hyperuricemia,
hypertension, and type 2 diabetes mellitus and tendon surgery
of her right thumb.
Figure 1 Family pedigree showing autosomal dominant inheritance
The filled upper right quadrant indicates myopathy, and the filled upper left quadrant indicates nonspecific neurologic symptoms. The arrow indicates the
proband.
Neurology.org/NG Neurology: Genetics | Volume 5, Number 4 | August 2019 3
Physical examination revealed mild distal extremity weakness
and diminished 1/4 reﬂexes bilaterally of her biceps, triceps,
brachioradialis, and patella. Her Achilles tendon reﬂex was
absent. She had a wide based and unbalanced gait with a lor-
dotic posture. There was no scapular winging, pes cavus,
skeletal dysplasia, respiratory distress, signs of cranial nerve
involvement, or sensory loss. CT of the lung revealed right
basilar consolidative inﬁltrate vs atelectasis at the left lung base.
Muscle biopsy of her left vastus lateralis revealed adipose
tissue inﬁltration, moderate to severe endomysial ﬁbrosis,
muscle ﬁber size variation, numerous atrophic muscle ﬁbers,
increase of internalized nuclei, and rimmed vacuoles. There
were no necrotic ﬁbers, regenerating muscle ﬁbers, or evi-
dence of inﬂammation (ﬁgure 3). No medications were pre-
scribed for this patient.
Case 3
The proband’s maternal uncle (III:15) is a 66-year-old man
who ﬁrst became aware of a steppage gait at 42 years and
weakness of his great toe and right hand at age 44 years. This
progressed to using a cane and diﬃculty going up stairs at age
46–47 years. At age 52 years, he started swimming instead of
running for exercise and starting to use Canadian crutches. At
age 59 years, he started using a manual wheelchair, and at age
64 years, he transitioned to a power wheelchair. At age 61
years, he has noticed that his breathing became more diﬃcult.
His medical history includes neurogenic bladder, mild ob-
structive sleep apnea, gout and hearing loss of his right ear,
and 20 incidences of recurrences of basal cell nevi and squa-
mous cell carcinoma of the skin.
On physical examination, there was no pes cavus, skeletal dys-
plasia, camptocormia, scapular winging, or signs of cranial nerve
or cerebellar involvement. He had reduced sensation to light
touch below knees bilaterally, and muscle strength examination
revealed distal > proximal weakness. TheMRC scales were neck
ﬂexion 4−/5, neck extension 4/5, shoulder abduction 4−/5,
elbow ﬂexion 4−/5 and extension 3+/5, ﬁnger abduction 5−/5,
hip ﬂexion 2/5 and extension 3+/5, knee ﬂexion 3+/5 and
extension 2/5, ankle dorsiﬂexion 1/5, and plantarﬂexion 3−/5.
EMG and nerve conduction studies (NCSs) revealed abnormal
ﬁndings suggestive of a myopathic pattern primarily in distal
musculature with evidence of a motor neuropathy.
Chest x-ray revealed low lung volumes without evidence of
cardiovascular disease. Pulmonary function tests revealed re-
strictive lung disease with poor lung capacity with a forced vital
capacity of 43%, and BiPAP was recommended. Cardiac CT
showed an elevated coronary calcium score of 244 but no
cardiomyopathy.
Body CT revealed atrophy and fatty inﬁltration of his psoas
muscle, benign prostatic hyperplasia, atelectasis with prom-
inent interstitial markings of his lung bases bilaterally, renal
cyst, gallstone, and a calciﬁed granuloma in his liver. No
medications were prescribed for this patient.
Family history of other relatives
Family history was signiﬁcant for the proband’s maternal
grandfather losing his ability to walk at age 38 years and for
developing cardiac problems in his ﬁfties. On review of the
extended family, his grandfather’s brother lost his ability to
walk at age 35 years, and the great grandmother lost her ability
to walk at age 56 years. Five other family members reported
nonspeciﬁc neurologic symptoms; however, these individuals
tested negative for the familial mutation. Figure 4 depicts the
pedigree with HSPB8 mutation status indicated with a “+.”
Figure 2 Muscular involvement of the HSPB8 disease
(A) Photograph of the proband showing scapular winging and bilateral
wasting of deltoids. (B) T1-weighted MRI of the proband showing severe
relatively symmetricmultifocal fatty degenerative changes of bilateral lower
extremities and (C) proximal lower extremities preferentially affecting the
vastus medialis and intermedius together with the adductor magnus and
semitendinosus on the thigh level, as well as predominately anterior and
lateral compartments more than soleus muscle of the distal legs.
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Molecular studies
Extensive neuromuscular 35-gene panel testing was negative
in the proband and uncle notably for facioscapulohumeral
muscular dystrophy, GNE and VCP associated hereditary
inclusion body myopathy. Full exome sequencing and
genotype-phenotype correlation based on exome data
analysis revealed notable alterations in CCDC78, HSPB8,
MUSK, MYH14, TRIM32, and TTN—none of which was
Figure 4 Sequencing of the HSPB8 gene
(A) Chromatogram from the proband revealing the frameshift mutation c.515dupC p.Pro173fs, which was similarly identified in all affected individuals. (B)
The mRNA that results from this mutation has 5 splice variants with size ranging from 27 to 244 aa. Only the first 3 contain an α-crystallin domain and are
coding. The red boxes are exons with their size being proportional to their length. The wide colored boxes are introns. Similarly colored introns are identical.
The purple introns are upstream open reading frames. The solid black vertical lines indicate validated cap sites at the 59 end, and the dotted black lines
indicate validated polyadenylation sites at the 39 end. The clear boxes are untranslated regions. (C) Conservation of the sequence of amino acidswithinHSPB8
across species reveals a very well conserved protein. (D) The predicted sequence of amino acids in themutant HSPB8 protein (214 amino acids) is longer than
its wild-type counterpart (196 amino acids).
Figure 3Muscle biopsy shows rimmed vacuoles
(A) Muscle histology of a biopsy of the
left vastus lateralis from case 2 shows
the presence of rimmed vacuoles (in 3
fibers), adipose replacement, moder-
ate to severe endomysial fibrosis,
muscle fiber size variation, numerous
atrophic muscle fibers, and increase
in central nuclei. (B) Semithin section
stained with toluidine blue showing
a single fiber with accumulated auto-
phagic vacuoles, corresponding to
rimmed vacuolar changes in muscle
cryosections.
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considered contributory based on the known molecular and
clinical spectrum of these genes at the time of testing. Sub-
sequent genome sequencing identiﬁed amutation in theHSPB8
gene identical to the French family 2, which had recently been
reported by Ghaoui et al.13 after whole-exome analysis.
HSPB8 p.Pro173fs
TheHSPB8 gene mutation identiﬁed consists of a duplication
of C at position 515, located in coding exon 3 (the last coding
exon) causing a translational frameshift with a predicted al-
ternate stop codon (c.515dupC, p.P173Sfs*43). The alter-
ation changes the remaining 25 amino acids of the protein and
elongates the protein by a further 18 amino acids (ﬁgure 4).
This variant is not observed in any of the control population
databases including gnomAD. The calculated severity score is
1.0 on a scale of 0.0–1.0. According to HumanGeneMutation
Database/ClinVar, the HSPB8 gene is associated with CMT
disease 2L; neuropathy, distal hereditary motor, type II; distal
myopathy and motor neuropathy; and distal hereditary motor
neuronopathy type 2. Recently, the 515dupC, p.P173Sfs*43
variant had been associated with a progressive distal myopa-
thy and neuropathy in a proband and his brother. Muscle
tissue in the proband showed increased internal nuclei, nu-
merous rimmed vacuolar ﬁbers, splitting, cytoplasmic bodies,
and moth-eaten ﬁbers.13
HSPB8 and autophagy protein expression in
mutant HSPB8 fibroblasts
Western blot densitometry exhibited up to 50% reduction of
HSPB8 protein expression level in ﬁbroblasts from patients with
the HSPB8 mutation c.515dupC, p.P173SFS*43 mutation com-
pared with control ﬁbroblasts (ﬁgure 5, A and B). The expression
of autophagosomal marker LC3B and autophagy receptor p62/
SQSTM1 was more pronounced in all patients’ ﬁbroblasts in
comparison to those from healthy subjects (ﬁgure 5).
HSPB8 protein expression under heat
shock conditions
As expected, heat shock led to a signiﬁcant induction of
HSPB8; however, following the recovery phase, an excessive
amount of HSPB8 protein aggregates was still present in all 3
heated ﬁbroblasts from patients compared with the unheated
ones. This phenomenon was not seen in healthy control cells
(ﬁgure 6).
Figure 5 Expression of HSPB8, LC3B, p62/SQSTM1, and BAG3 proteins comparison in patients versus controls
(A)Western blot revealed lowHSPB8, increased autophagy (LC3, p62) protein expression in patient fibroblasts comparedwith age- and sex-matched controls.
GAPDHwas used as a positive loading control. (B) Densitometry analyses of theWestern blot results (C) Immunocytochemistry images by confocalmicrocopy
confirmed Western blotting data. Pair 1: patient (P1) and control (C1) fibroblasts; pair 2: P2 and C2; pair 3: P3 and C3.
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Discussion
HSPB8 is part of the chaperone-assisted selective autophagy
(CASA) complex previously associated with CMT type
2L10,11 and distal hereditary motor neuropathy type IIa.12
Only recently has the new association of hereditary rimmed
vacuolar neuromyopathy been described with mutations in
theHSPB8 gene.13–15 We report 3 patients from a new family
with histologic features of myoﬁbrillar myopathy with
aggregates and rimmed vacuoles. The onset of the disease is
very similar to the other reported families13–15 and manifests
as a myopathy before age 50 years aﬀecting the lower ex-
tremities more commonly than the upper extremities. The
MRI distribution of muscle involvement in our cohort
includes muscles of the distal lower extremities similar to
previous studies13 that described T1-weighed MRI ﬁndings
of the lower limb muscles and demonstrated diﬀuse tissue
changes early in the disease stage progressing later
to fatty replacement typical of a myopathy. In addition,
there was a previous report of 5 cases from 2 families and
a sporadic case, all with the same HSPB8 c.508_509delCA
(p.Gln170Glyfs*45) mutation predicted to induce a frame-
shift from amino acid 170 leading to modiﬁcation of the last
27 amino acids and to 17 additional amino acids.14 Individuals
had bilateral foot drop starting at age 40 years, histology of
muscle demonstrated a dystrophic and myoﬁbrillar myopathy
pattern, and MRI showed fatty changes in several muscles
including paraspinal muscles and lower limb muscles in-
cluding the vastus muscles, tibialis anterior, and extensor
digitorum longus similar to those reported previously13
(table). Most recently, triplets and their mother were reported
with distal and proximal muscle weakness, EMG showed
mixed myopathic and neurogenic changes, and NCSs showed
ﬁndings of an axonal neuropathy.15 Muscle biopsy ﬁndings
were that of a primary myopathy with rimmed vacuoles in
20% of patients, and MRI revealed fatty degeneration mostly
in the quadriceps, adductor magnus, medial gastrocnemius,
and peroneus muscles (table).
The family of small heat shock proteins (HSPBs1–10) (22
kDa) represents an important group of ubiquitous proteins
involved in several key processes of cellular physiology, such
as cell survival, cytoskeletal remodeling, and protein degra-
dation. Aberrant chaperone function is the likely mechanisms
for the pathologic protein aggregation seen in HSPB8 disease.
The HSPB8 c.K141E mutation associated with CMT impairs
chaperone activity,21 which suggests that the defective or
decreased activity is associated with the deteriorating motor
neuron function. HSPB8 expression within motor neurons
declines with age,20 which has been hypothesized as the
mechanism of the disease presenting in older ages and pro-
gressing with age.18 A contributing factor to the susceptibility
of these patients may be impaired formation of neurites in
HSPB8 mutants.22 The HSPB8 pathology is similar to the
Figure 6 Expression of HSPB8 protein under heat shock condition
(A) No heat shock condition, (B) heat shock condition. An increase in the amount of HSPB8 protein was present in 3 heated fibroblasts from patients (B1)
compared with nonheated fibroblasts (A1). This phenomenon was not observed in control cells (A2 and B2). Pair 1: patient (P1) and control (C1) fibroblasts;
pair 2: P2 and C2; pair 3: P3 and C3.
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Table Reported families with HSPB8-related myopathy
Individual Reference Mutation Relationship Ancestry Sex
Age
(y)
Age at
onset (y) CPK (U/L) EMGa NCS
RVM
phenotype
1 This study c.515dupC,
p.P173SFS*43
Proband French M 44 35 430 +/− Normal −
2 Mother F 64 56 370 −/− Normal +
3 Uncle M 66 42 327 +/+ Motor neuropathy with both axonal and demyelinating
neuroapathy
−
4 13 c.421A. G,
p.K141E
Proband—family I English M 30 22 850–2,000 +/+ Length-dependent axonal motor neuropathy predominantly
affecting the lower limbs
+
5 Mother—family I F 56 Childhood 269 +/+ Predominantly lower limb axonal motor neuropathy +
6 c.151insC
p.P173SfsX43
Proband—family II French M 62 46 369 −/+ Normal −
7 14 c.508_509delCA,
pGln170Glyfs*45
Proband—family A II2 French M 57 40 449 +/− Normal NA
8 Brother—family A II8 M 55 35 900 +/− +
9 Daughter, family A III2 F 45 40 186 +/− +
10 Proband, family B III1 M 64 40 214 +/− NA
Proband, family C II1 F 74 40 282 +/− NA
12 15 c.421A>G,
p.K141E
Proband II1 Italian F 31 20 274 +/+ Reduced compound motor action potential amplitudes in
lower limbs
+
13 Proband sibling II2 Italian M 31 Early 20s 656 +/+ Absent tibial compound motor action potential bilaterally and
reduced peroneal motor compound action potential
amplitude. Normal conduction velocities.
+
14 Proband sibling II3 Italian F 31 Late 20s a −/− Normal at 15 years. −
15 Proband mother I1 Italian F 58 30 b +/+ Axonal motor neuropathy −
Mean 8M/
7F
51.2 33.3 517.4 42.8% abnormal 47%
positive
Abbreviations: CPK = creatinine phosphokinase; NCS = nerve conduction study; RVM = rimmed vacuolar myopathy.
a Raised.
b Moderately increased CPK.
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pathology in myopathies due to gene defects in other com-
ponents of the CASA complex such as BAG3 and DNAJB6.
Based on results from animal studies, there has been suggestion
of a toxic gain-of-function mechanism for HSPB8 associated
CMT.23 However, our Western blot densitometry studies
exhibited a 50% reduction of HSPB8 protein expression level in
patients compared with control ﬁbroblasts (ﬁgure 5). Recently,
it was noted14 that N-terminal targeting of the protein did not
detect this elongated protein suggesting mRNA decay or pro-
tein degradation.24 In addition, HSPB8 was decreased by 60%
byWestern blot quantiﬁcation. The consequences of the eﬀects
of the mutant protein are diﬃcult to predict based on current
knowledge because HSPB8 acts in complexes with other
chaperones, especially in muscle tissue. The negative eﬀects on
the multiprotein complexes may be explained by a dominant
negative eﬀect, but haploinsuﬃciency cannot be excluded. The
clear increase of p62 and LC3 in the patient muscle suggests
a harmful eﬀect of the mutant protein rather than rapid deg-
radation of the mutant. To clarify this in more detail, a mutant
protein–speciﬁc antibody would be required to check for
eventual accumulation or degradation of the mutant.
Most reported mutations, including the c.515dupC mutation,
have occurred within the α-crystallin domain that manifests
chaperone activity.25 Previous studies have shown greater binding
of these HSPB8 mutants to the interacting partner HSPB1. Ex-
pression of mutant HSPB8 containing the K141C terminal
mutations found in hereditarymotor and sensory neuropathies in
cultured cells had signiﬁcantly reduced chaperone activity and
increased aggregation compared with wild-type protein.12
In stress conditions, like heat shock, small heat shock proteins
such as HSPB8 increase in concentration to perform their
chaperone activity by binding to misfolded protein and
blocking the formation of aggregates. During recovery from
heat shock under normal conditions, the transcription factor
NF-κB (Nuclear factor kappa-light-chain-enhancer of acti-
vated B cells) activates the removal of misfolded or aggregated
proteins by governing the expression of HSPB8, thereby in-
creasing cell survival.26 Our studies indicate that patient cells
could not recover after the heat shock stress and displayed an
increased HSPB8 expression, also noted by Irobi et al.27
We report a new family with HSPB8-associated autosomal
dominant RVM, caused by a c.515dupC frameshift mutation
resulting in an elongated protein. The clinical features in these
individuals bear similarity with recently reported cases. We
note reduced expression of HSPB8 in patient ﬁbroblasts
compared with age- and sex-matched control ﬁbroblasts
supporting our proposal of haploinsuﬃciency as the mecha-
nism of disease in this newly described disorder.
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